Clinical Trials Browser

Phase 1 × Deferasirox × Clear all

NCT02413021 2016-02-25

The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy Regimens

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma